INVA Innoviva Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INVA

Price (delayed)

$11.43

Market cap

$1.16B

P/E Ratio

5.17

Dividend/share

N/A

EPS

$2.21

Enterprise value

$1.3B

Sector: Healthcare
Industry: Biotechnology
Website: https://www.inva.com/

Highlights

The equity has surged by 72% year-on-year and by 11% since the previous quarter
The stock's price to earnings (P/E) is 61% less than its 5-year quarterly average of 13.2 and 11% less than its last 4 quarters average of 5.8
Innoviva's quick ratio has plunged by 62% from the previous quarter and by 30% YoY
The debt has grown by 2.2% YoY

Key stats

What are the main financial stats of INVA
Market
Shares outstanding
101.39M
Market cap
$1.16B
Enterprise value
$1.3B
Valuations
Price to earnings (P/E)
5.17
Price to book (P/B)
2.15
Price to sales (P/S)
3.44
EV/EBIT
4.28
EV/EBITDA
4.09
EV/Sales
3.85
Earnings
Revenue
$336.79M
EBIT
$303.16M
EBITDA
$317M
Free cash flow
$313.1M
Per share
EPS
$2.21
Free cash flow per share
$3.09
Book value per share
$5.33
Revenue per share
$3.32
TBVPS
$9.87
Balance sheet
Total assets
$999.57M
Total liabilities
$391.73M
Debt
$385.52M
Equity
$539.91M
Working capital
$335.95M
Liquidity
Debt to equity
0.71
Current ratio
55.98
Quick ratio
55.71
Net debt/EBITDA
0.44
Margins
EBITDA margin
94.1%
Gross margin
100%
Net margin
66.6%
Operating margin
95.3%
Efficiency
Return on assets
25%
Return on equity
48.2%
Return on invested capital
33.6%
Return on capital employed
30.5%
Return on sales
90%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INVA stock price

How has the Innoviva stock price performed over time
Intraday
-1.64%
1 week
-2.64%
1 month
-8.63%
1 year
-16.57%
YTD
-7.75%
QTD
-7.75%

Financial performance

How have Innoviva's revenue and profit performed over time
Revenue
$336.79M
Gross profit
$336.79M
Operating income
$321.12M
Net income
$224.4M
Gross margin
100%
Net margin
66.6%
INVA's net income is up by 43% year-on-year and by 3.7% since the previous quarter
INVA's operating income is up by 30% YoY and by 3.6% QoQ
The gross profit is up by 29% YoY and by 4.5% from the previous quarter
The revenue has grown by 29% YoY and by 4.5% from the previous quarter

Growth

What is Innoviva's growth rate over time

Valuation

What is Innoviva stock price valuation
P/E
5.17
P/B
2.15
P/S
3.44
EV/EBIT
4.28
EV/EBITDA
4.09
EV/Sales
3.85
The stock's price to earnings (P/E) is 61% less than its 5-year quarterly average of 13.2 and 11% less than its last 4 quarters average of 5.8
The company's EPS rose by 43% YoY and by 3.3% QoQ
The equity has surged by 72% year-on-year and by 11% since the previous quarter
The P/B is 20% below the last 4 quarters average of 2.7
The P/S is 54% lower than the 5-year quarterly average of 7.4 and 14% lower than the last 4 quarters average of 4.0
The revenue has grown by 29% YoY and by 4.5% from the previous quarter

Efficiency

How efficient is Innoviva business performance
The return on invested capital is up by 35% year-on-year but it has declined by 5% since the previous quarter
INVA's return on equity is down by 24% year-on-year and by 9% since the previous quarter
The company's return on sales rose by 8% YoY
INVA's ROA is up by 4.6% YoY but it is down by 4.2% from the previous quarter

Dividends

What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INVA.

Financial health

How did Innoviva financials performed over time
The total assets is 155% greater than the total liabilities
Innoviva's quick ratio has plunged by 62% from the previous quarter and by 30% YoY
The company's current ratio has shrunk by 62% QoQ and by 30% YoY
The debt is 29% less than the equity
The equity has surged by 72% year-on-year and by 11% since the previous quarter
The debt to equity has declined by 41% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.